Cilostazol ( DrugBank: Cilostazol )


3 diseases
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ2
51全身性強皮症1
70広範脊柱管狭窄症1

46. 悪性関節リウマチ


臨床試験数 : 4,356 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05671497
(ClinicalTrials.gov)
November 1, 202214/12/2022The Effect of Cilostazol on Rheumatoid Arthritis PatientsEvaluation of the Effect of Cilostazol on the Clinical Outcomes of Rheumatoid Arthritis PatientsRheumatoid ArthritisDrug: Cilostazol 100 MG;Drug: conventional synthetic antirheumatic drugsAin Shams UniversityMisr International University;Al-Azhar UniversityRecruiting19 YearsN/AAll70Phase 2/Phase 3Egypt
2NCT05594680
(ClinicalTrials.gov)
November 1, 202218/10/2022Cilostazol and Methotrexate in Rheumatoid ArthritisThe Phosphodiesterase 3 Inhibitor Cilostazol as Adjunct to Methotrexate in Patients With Rheumatoid ArthritisRheumatoid ArthritisDrug: Cilostazol;Drug: Methotrexate;Drug: PlaceboTanta UniversityNULLNot yet recruiting18 Years60 YearsAll70Phase 3NULL

51. 全身性強皮症


臨床試験数 : 525 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-019977-14-IT
(EUCTR)
04/11/201027/12/2010Efficacy of Cilostazol for the treatment of Raynaud’s Phenomenon in patients affected by Systemic Sclerosis - NDEfficacy of Cilostazol for the treatment of Raynaud’s Phenomenon in patients affected by Systemic Sclerosis - ND Patients affected by Systemic Sclerosis with Raynaud’s Phenomenon
MedDRA version: 9.1;Level: LLT;Classification code 10042953
Trade Name: PLETAL
INN or Proposed INN: CILOSTAZOL
AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVANULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Italy

70. 広範脊柱管狭窄症


臨床試験数 : 95 薬物数 : 169 - (DrugBank : 61) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 90
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000006588
2011/11/0101/11/2011Effect of antiplatelet agent on muscle cramps after surgery of lumbar spinal stenosis in patients with lumbar spinal canal stenosis and peripheral artery diseaseEffect of antiplatelet agent on muscle cramps after surgery of lumbar spinal stenosis in patients with lumbar spinal canal stenosis and peripheral artery disease - Effect of antiplatelet agent on muscle cramps after surgery of lumbar spinal stenosis in patients with lumbar spinal canal stenosis and peripheral artery disease Lumbar spinal canal stenosisContinuous administration of cilostazolJuntendo UniversityDepartment of Orthopaedic SurgeryNULLRecruitingNot applicableNot applicableMale and Female30Not applicableJapan